cCAM Biotherapeutics

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

CellmAbs

This biotech company develops monoclonal antibodies and adoptive cell therapies to treat oncology patients with solid tumours.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Cadeo Oncology

The company develops monoclonal antibody-based immunotherapy treatments for cancer patients to induce programmed cell death in cancer cells.

CMPI

This biopharmaceutical company develops cancer immunotherapies that activate the immune system to treat patients with advanced solid tumours, such as metastatic melanoma.

Tacalyx

This company develops antibody-based therapeutics targeting tumour associated carbohydrate antigens for the treatment of solid tumours in cancer patients.

Caedo Oncology

This company develops monoclonal antibody therapeutics that induce programmed cell death in cancer cells for healthcare providers and patients.

Cellemedy

The company develops next-generation protein therapeutics and immuno-oncology drugs for patients suffering from cancer.